1. Home
  2. IRON vs SXT Comparison

IRON vs SXT Comparison

Compare IRON & SXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$94.29

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Logo Sensient Technologies Corporation

SXT

Sensient Technologies Corporation

HOLD

Current Price

$90.63

Market Cap

4.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRON
SXT
Founded
2017
1882
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
4.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IRON
SXT
Price
$94.29
$90.63
Analyst Decision
Strong Buy
Buy
Analyst Count
12
2
Target Price
$108.83
$110.00
AVG Volume (30 Days)
533.0K
283.7K
Earning Date
11-06-2025
10-31-2025
Dividend Yield
N/A
1.77%
EPS Growth
N/A
56.32
EPS
N/A
3.27
Revenue
N/A
$1,595,084,000.00
Revenue This Year
N/A
$4.80
Revenue Next Year
N/A
$5.94
P/E Ratio
N/A
$28.25
Revenue Growth
N/A
4.25
52 Week Low
$30.82
$66.15
52 Week High
$97.12
$121.54

Technical Indicators

Market Signals
Indicator
IRON
SXT
Relative Strength Index (RSI) 62.96 39.48
Support Level $87.18 $92.41
Resistance Level $96.18 $96.77
Average True Range (ATR) 3.94 2.30
MACD -0.32 -0.33
Stochastic Oscillator 56.25 4.54

Price Performance

Historical Comparison
IRON
SXT

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About SXT Sensient Technologies Corporation

Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. Its principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's reportable segments are; Flavors & Extracts, which derive key revenue, Color, Asia Pacific, and Corporate and Other. Geographically, the company generates maximum revenue from North America, followed by Europe, Asia-Pacific, and other regions.

Share on Social Networks: